Other Species / Isoforms
  RMI2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S7-p
_MAAAADsFSGGPAG
Upstream
0 3
Treatment
  • nocodazole
RMI2 (human) _MAAAADsFSGGPAG S7-p
RMI2 (mouse) MAAAASESLSSGGPG S8
RMI2 (rat) MAAAASESLSSGGPG S8
R16-m1
SGGPAGVrLPRsPPL
0 1
RMI2 (human) SGGPAGVrLPRsPPL R16-m1
RMI2 (mouse) SGGPGAVRLPRLPPL R18
RMI2 (rat) SGGPGAVRLPRSPPL R18
S20-p
AGVrLPRsPPLkVLA
0 5
RMI2 (human) AGVrLPRsPPLkVLA S20-p
RMI2 (mouse) GAVRLPRLPPLKVLA L22
RMI2 (rat) GAVRLPRSPPLKVLA S22
K24-ub
LPRsPPLkVLAEQLr
0 1
RMI2 (human) LPRsPPLkVLAEQLr K24-ub
RMI2 (mouse) LPRLPPLKVLAGQLR K26
RMI2 (rat) LPRSPPLKVLAEQLR K26
R31-m1
kVLAEQLrRDAEGGP
0 1
RMI2 (human) kVLAEQLrRDAEGGP R31-m1
RMI2 (mouse) KVLAGQLRRHAEGGP R33
RMI2 (rat) KVLAEQLRQHAEGGP R33
R42-m1
EGGPGAWrLSRAAAG
0 1
RMI2 (human) EGGPGAWrLSRAAAG R42-m1
RMI2 (mouse) EGGPGAWRLSRAAVG R44
RMI2 (rat) EGGPGAWRLSRAAVG R44
R84-m1
PSGDFSVrGLERVPR
0 1
RMI2 (human) PSGDFSVrGLERVPR R84-m1
RMI2 (mouse) SSGAFSVRGLERVPR R86
RMI2 (rat) PSGTFSVRGLERVPR R86
S112-p
MGVVQACsPEPCLQA
Upstream
Downstream
1 1
Effects on Biological Processes:
  • cell cycle regulation
Putative in vivo kinases:
  • TTK (human)
Treatment
  • siRNA
RMI2 (human) MGVVQACsPEPCLQA S112-p
RMI2 (mouse) MGVVQACSPEPCLQA S114
RMI2 (rat) MGVVQACSPEPCLQA S114